EVOKE PHARMA INC's ticker is EVOK and the CUSIP is 30049G104. A total of 22 filers reported holding EVOKE PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $0 | – | 48 | +269.2% | 0.00% | – |
Q2 2021 | $0 | -100.0% | 13 | -99.8% | 0.00% | – |
Q1 2021 | $12,000 | -42.9% | 6,200 | -25.3% | 0.00% | – |
Q4 2020 | $21,000 | +600.0% | 8,300 | +105.4% | 0.00% | – |
Q2 2019 | $3,000 | -62.5% | 4,041 | +41.9% | 0.00% | – |
Q3 2018 | $8,000 | -75.8% | 2,848 | -71.5% | 0.00% | – |
Q3 2017 | $33,000 | +26.9% | 10,000 | 0.0% | 0.00% | – |
Q2 2017 | $26,000 | +23.8% | 10,000 | +45.5% | 0.00% | – |
Q1 2017 | $21,000 | +425.0% | 6,875 | +266.7% | 0.00% | – |
Q4 2016 | $4,000 | 0.0% | 1,875 | 0.0% | 0.00% | – |
Q3 2016 | $4,000 | -80.0% | 1,875 | -35.1% | 0.00% | – |
Q2 2016 | $20,000 | +33.3% | 2,887 | +0.4% | 0.00% | – |
Q1 2016 | $15,000 | +66.7% | 2,875 | 0.0% | 0.00% | – |
Q4 2015 | $9,000 | -83.0% | 2,875 | -84.3% | 0.00% | – |
Q3 2015 | $53,000 | -44.8% | 18,275 | 0.0% | 0.00% | – |
Q2 2015 | $96,000 | -25.6% | 18,275 | 0.0% | 0.00% | – |
Q1 2015 | $129,000 | +41.8% | 18,275 | +18.7% | 0.00% | – |
Q4 2014 | $91,000 | +116.7% | 15,400 | +100.0% | 0.00% | – |
Q3 2014 | $42,000 | -84.5% | 7,700 | -77.0% | 0.00% | – |
Q2 2014 | $271,000 | -3.6% | 33,500 | 0.0% | 0.00% | – |
Q1 2014 | $281,000 | +8.9% | 33,500 | -3.0% | 0.00% | – |
Q4 2013 | $258,000 | – | 34,529 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 242,500 | $1,962,000 | 1.69% |
SOPHROSYNE CAPITAL LLC | 49,000 | $397,000 | 0.40% |
LMR Partners LLP | 23,882 | $187,000 | 0.02% |
GEODE CAPITAL MANAGEMENT, LLC | 10,276 | $80,000 | 0.00% |
BlackRock Investment Management, LLC | 489 | $4,000 | 0.00% |
MORGAN STANLEY | 500 | $4,000 | 0.00% |
Tower Research Capital LLC (TRC) | 84 | $1,000 | 0.00% |
VANGUARD GROUP INC | 48,394 | $378,000 | 0.00% |
UBS AG | 727 | $6,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 33,500 | $271,000 | 0.00% |